| Type | Public |
|---|---|
| Traded as | (NYSE: COO) |
| Industry | Pharmaceuticals |
| Predecessor | Martin H. Smith Co., Cooper Tinsley Laboratories, Inc. |
| Founded | 1958 |
| Headquarters | Pleasanton, California |
| Area served | Worldwide |
| Key people | Robert S. Weiss, CEO & Director |
| Products | Contact lenses, medical products and equipment for treating women |
| Revenue | US$1331 billion (2011)[1] |
| Operating income | US$228 million (2011)[1] |
| Net income | US$175 million (2011)[1] |
| Total assets | US$2625 million (2011)[1] |
| Total equity | US$1937 million (2011)[1] |
| Employees | 7400 (2011)[1] |
| Divisions | CooperVision (CVI), CooperSurgical (CSI) |
| Website | www.coopercos.com |
The Cooper Companies is an American medical company. Subsidiary CooperVision was founded in 1979 and is the 4th largest contact lens maker in the world and the number one manufacturer of toric lenses.[2] CooperSurgical makes products for the woman's healthcare market.
With headquarters in Pleasanton, California it manufactures in Juana Díaz, Puerto Rico; Norfolk, Virginia; Rochester, New York; Adelaide, Australia; Hamble in Hampshire England; and Madrid, Spain.